Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/30/2022 | $3.10 | Buy | Citigroup |
Citigroup resumed coverage of iHuman with a rating of Buy and set a new price target of $3.10
BEIJING, Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenues were RMB215.1 million (US$29.6 million), compared with RMB241.0 million in the same period last year.Gross profit was RMB151.7 million (US$20.9 million), compared with RMB170.8 million in the same period last year.Operating income was RMB18.8 million (US$2.6 million), compared wi
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Tuesday, September 24 and Wednesday, September 25, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US. Representatives from participating companies based in China, France, Hong Kong, Netherlands, Philippines, Portugal, Spain, Switzerland, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log i
BEIJING, June 28, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Revenues were RMB235.0 million (US$32.5 million), compared with RMB265.2 million in the same period last year.Gross profit was RMB168.1 million (US$23.3 million), compared with RMB185.6 million in the same period last year.Operating income was RMB17.5 million (US$2.4 million), compared with
SCHEDULE 13G/A - iHuman Inc. (0001814423) (Subject)
SCHEDULE 13G/A - iHuman Inc. (0001814423) (Subject)
6-K - iHuman Inc. (0001814423) (Filer)
BEIJING, Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenues were RMB215.1 million (US$29.6 million), compared with RMB241.0 million in the same period last year.Gross profit was RMB151.7 million (US$20.9 million), compared with RMB170.8 million in the same period last year.Operating income was RMB18.8 million (US$2.6 million), compared wi
BEIJING, June 28, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Revenues were RMB235.0 million (US$32.5 million), compared with RMB265.2 million in the same period last year.Gross profit was RMB168.1 million (US$23.3 million), compared with RMB185.6 million in the same period last year.Operating income was RMB17.5 million (US$2.4 million), compared with
BEIJING, Feb. 29, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenues were RMB250.4 million (US$35.3 million), compared with RMB260.7 million in the same period last year.Gross profit was RMB178.2 million (US$25.1 million), compared with RMB181.0 million in the same period last year.Operating income was RMB21.9 million (US$3.1 mi
Key Takeaways: iHuman’s revenue and profit both declined in the first quarter as it accelerated a global expansion plan to diversify beyond its softening home market in China The company’s gross margin and total users both improved, but the omission of its latest paid user count suggests that key metric continued to decline By Doug Young Sometimes what’s left unsaid speaks the loudest. That could partly explain the 4.3% decline for shares of iHuman Inc. (NYSE:IH), a provider of educational products and services for young children, after it published its latest quarterly results last Friday. The report notably didn’t include the company’s latest number of paying users at the end of Ma
Gainers Hanryu Holdings (NASDAQ:HRYU) shares moved upwards by 21.6% to $0.61 during Monday's pre-market session. The market value of their outstanding shares is at $32.1 million. Leafly Holdings (NASDAQ:LFLY) stock increased by 16.02% to $2.72. The market value of their outstanding shares is at $6.2 million. Treasure Global (NASDAQ:TGL) shares rose 13.42% to $4.9. The market value of their outstanding shares is at $6.3 million. Collective Audience (NASDAQ:CAUD) shares rose 7.52% to $0.51. The market value of their outstanding shares is at $7.0 million. TruGolf Holdings (NASDAQ:TRUG) shares increased by 5.71% to $1.85. The market value of their outstanding shares is at $24.5 million. Tu
SC 13G/A - iHuman Inc. (0001814423) (Subject)
SC 13G/A - iHuman Inc. (0001814423) (Subject)
SC 13G - iHuman Inc. (0001814423) (Subject)